M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Mast Therapeutics acquires Aires Pharmaceuticals in all-stock transaction
Biopharmaceutical company Mast Therapeutics (NYSE MKT:MSTX) disclosed on Thursday the completion of the acquisition of Aires Pharmaceuticals in an all-stock transaction.
In the all-stock transaction, Mast Therapeutics issued a total of 5.2m shares of its common stock, representing...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives